3 -deazapurine derivatives as TLR7 modulators

Details for Australian Patent Application No. 2007216247 (hide)

Owner Pfizer Limited

Inventors Tran, Thien Duc; Pryde, David Cameron; Jones, Peter

Agent Spruson & Ferguson

Pub. Number AU-A-2007216247

PCT Pub. Number WO2007/093901

Priority 60/829,730 17.10.06 US; 60/774,580 17.02.06 US; 60/870,020 14.12.06 US

Filing date 5 February 2007

Wipo publication date 23 August 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/80 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/093901 Priority application(s): WO2007/093901

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007216255-Novel pharmaceutical compositions for optimizing substitution treatments and extending the pharmacopoeia to global treatment of addictions

2007216240-Mechanical locking differential lockout mechanism